InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Virnich Daniel, Chief Executive Officer. Insider active across 1 company, notably Oncology Institute, Inc.. In total, 21 disclosures have been published. Split: 1 buy · 1 sell. Total volume traded: €29k. History available since 12 November 2021. The latest transaction was filed on 27 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Virnich Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
670,608 shares0Common StockSEC:0001079973-26-000439:0
98,534 shares@ US$3.0750.0% of flowCommon StockSEC:0001079973-26-000439:1
11,834 shares@ US$3.596.6% of flowCommon StockSEC:0001079973-26-000332:0
6,464 shares0Common StockSEC:0001079973-25-001809:0
6,211 shares0Common StockSEC:0001079973-25-001765:0
20,388 shares@ US$2.67518.3% of flowCommon stockSEC:0001628280-25-027210:0
1,083,334 shares0Common stockSEC:0001799191-25-000017:0
22,640 shares@ US$1.04178.3% of flowCommon StockSEC:0001079973-25-000529:0
Canonical exit: 24 Jun 2025 (T+90)
10,261 shares@ US$0.8893.2% of flowCommon stockSEC:0001799191-25-000008:0
4,750 shares@ US$0.1360.2% of flowCommon stockSEC:0001799191-24-000043:0
78,094 shares0Common stockSEC:0001799191-24-000033:0
11,173 shares@ US$0.59722.3% of flowCommon StockSEC:0001799191-24-000011:0
4,322 shares@ US$2.1933.3% of flowCommon stockSEC:0001628280-23-039911:0
4,604 shares@ US$2.3853.9% of flowCommon stockSEC:0001628280-23-039300:0
114,944 shares0Common stockSEC:0001628280-23-008830:0
175,000 shares@ US$0.8654.8% of flowCommon StockSEC:0001799191-22-000056:0
3,767 shares@ US$2.02782.8% of flowCommon StockSEC:0001799191-22-000054:0
40,101 shares0Common StockSEC:0001799191-22-000044:0
3,767 shares@ US$2.02782.8% of flowCommon StockSEC:0001799191-22-000016:0
42,015 shares0Common stockSEC:0001628280-22-007098:0
78,094 shares0Common StockSEC:0001104659-21-140221:0
21 of 21 declarations
About Virnich Daniel
Virnich Daniel is Directeur Général et Président, and Chief Executive Officer at Oncology Institute, Inc. The 21 filings recorded cover the period from 2021-11-16 to 2026-04-01 in the sampled filings, with buy volume of EUR 21862 and sell volume of EUR 96950; the modal transaction nature is Attribution.
